Cumberland Pharmaceuticals (CPIX) Cash & Equivalents (QoQ) (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) Cash & Equivalents (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.01 Bn | 20.85 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.41 Bn | 18.61 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn |
| 10 | Cumberland Pharmaceuticals | 101.36 Mn | 90.35 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82% |
| Dec 31, 2025 | -24.69% |
| Sep 30, 2025 | -5.54% |
| Jun 30, 2025 | 6.48% |
| Mar 31, 2025 | -15.90% |
| Dec 31, 2024 | 2.86% |
| Sep 30, 2024 | 0.74% |
| Jun 30, 2024 | -6.53% |
| Mar 31, 2024 | 1.24% |
| Dec 31, 2023 | -1.01% |
| Sep 30, 2023 | 1.42% |
| Jun 30, 2023 | 11.37% |
| Mar 31, 2023 | -17.07% |
| Dec 31, 2022 | 1.11% |
| Sep 30, 2022 | 7.27% |
| Jun 30, 2022 | 5.50% |
| Mar 31, 2022 | -36.15% |
| Dec 31, 2021 | 4.63% |
| Sep 30, 2021 | 0.67% |
| Jun 30, 2021 | 3.00% |